Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	295.20B
Revenue (ttm)	590.23B
Net Income (ttm)	29.45B
Shares Out	11.81M
EPS (ttm)	2,374.00
PE Ratio	10.53
Forward PE	n/a
Dividend	630.00 (2.52%)
Ex-Dividend Date	Mar 28, 2025

Volume	32,346
Average Volume	23,057
Open	25,900
Previous Close	25,850
Day's Range	24,800 - 26,050
52-Week Range	21,800 - 36,250
Beta	0.23
RSI	40.63
Earnings Date	Mar 20, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.